UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000021690 |
|---|---|
| Receipt number | R000025019 |
| Scientific Title | Comparison of aquous humor VEGF concentration in patients with and without glaucoma |
| Date of disclosure of the study information | 2016/03/30 |
| Last modified on | 2017/03/31 23:43:39 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Comparison of aquous humor VEGF concentration in patients with and without glaucoma
Acronym
Aquous humor VEGF concentration in patients with glaucoma
Scientific Title
Comparison of aquous humor VEGF concentration in patients with and without glaucoma
Scientific Title:Acronym
Aquous humor VEGF concentration in patients with glaucoma
Region
| Japan |
Condition
Condition
glaucoma
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To compare aqueous humor levels of vascular endothelial growth factor in patients with and without glaucoma
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
aqueous humor levels of VEGF
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Other |
Interventions/Control_1
Measurement of aqueous humor levels of VEGF in patients with and without glaucoma
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with glaucoma
Key exclusion criteria
Patients with any other disease that could affect intraocular VEGF levels, such as diabetic retinopathy, retinal vein occlusion, and age-related macular degeneration
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Takayuki Minamikawa |
Organization
Shiga University ofMedical Science
Division name
Ophthalmology
Zip code
Address
Seta Tsukinowacho, Otsu, Shiga 520-2192, Japan
TEL
077-548-2276
mnmkw@belle.shiga-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yusuke Ichiyama |
Organization
Shiga University ofMedical Science
Division name
Ophthalmology
Zip code
Address
Seta Tsukinowacho, Otsu, Shiga 520-2192, Japan
TEL
077-548-2276
Homepage URL
ichiyama@belle.shiga-med.ac.jp
Sponsor or person
Institute
Shiga University of Medical Science
Institute
Department
Personal name
Funding Source
Organization
Shiga University of Medical Science
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 03 | Month | 30 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2015 | Year | 12 | Month | 22 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 03 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
| 2017 | Year | 03 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2016 | Year | 03 | Month | 30 | Day |
Last modified on
| 2017 | Year | 03 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025019
